Inhibiting the GPI Transamidase Subunit GPAA1 Abolishes CD24 Surface Localization and Enhances Macrophage-Mediated Phagocytosis of Ovarian Cancer Cells
Mishra, A. K.; Ye, T.; Banday, S.; Thakare, R. P.; Su, C. C. T.-T.; Pham, N. N. H.; Ali, A.; Kulshreshtha, A.; Chowdhury, S. R.; Simone, T. M.; Hu, K.; Zhu, L. J.; Eisenhaber, B.; Deibler, S. K.; Simin, K.; Thompson, P. R.; Eisenhaber, F.; Malonia, S. K.; Green, M. R.
Show abstract
The CD24-Siglec10 signaling axis is an immune checkpoint pathway that shields ovarian cancer cells from phagocytosis by tumor-associated macrophages (TAMs), making it an appealing immunotherapeutic target. Here, we investigate factors influencing CD24 cell surface expression and assess their suitability as drug targets. Using a CRISPR-based knockout screen, we identify GPAA1 (glycosylphosphatidylinositol anchor attachment-1) as a positive regulator of CD24 cell surface expression. GPAA1 is a crucial component of the multi-subunit GPI transamidase complex, which facilitates the attachment of GPI lipid anchor to the C-terminus of CD24, enabling its surface localization. Reducing the activity of GPAA1 in ovarian cancer cells, either by genetic ablation or targeting with an aminopeptidase inhibitor bestatin, disrupts GPI attachment to CD24. This disruption impairs CD24 cell surface localization, enhances phagocytosis by TAMs, and suppresses tumor growth in mice. Our study highlights the potential of GPAA1 targeting as a therapeutic approach for CD24-positive ovarian cancers.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mitochondrial metabolism sustains CD8+ T cellmigration for an efficient infiltration into solid tumors 95%
- Cycling Molecular Assemblies for Selective Cancer Cell Golgi Disruption 95%
- Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors 95%
Similar papers in this journal
- P-cadherin mechanoactivates tumor- mesothelium metabolic coupling to promote ovarian cancer metastasis 96%
- Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesis 95%
- Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells 94%
Similar papers in this journal
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 95%
- EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes 95%
- Neoplastic immune mimicry potentiates breast tumor progression 95%
Similar papers in this journal
- Phosphate dysregulation via the XPR1:KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer 95%
- Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma 95%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.